NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1069 coverBASIC AND CLINICAL ASPECTS OF NEUROENDOCRINE IMMUNOLOGY IN RHEUMATIC DISEASES Volume 1069 published June 2006
Ann. N.Y. Acad. Sci. 1069: 364–376 (2006). doi: 10.1196/annals.1351.034
Copyright © 2006 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by DI SIMONE, N.
Articles by CARUSO, A.
Search for Related Content
PubMed
PubMed Citation
Articles by DI SIMONE, N.
Articles by CARUSO, A.

Anti-Beta-2 Glycoprotein I Antibodies Affect Bcl-2 and Bax Trophoblast Expression without Evidence of Apoptosis

NICOLETTA DI SIMONEa, ROBERTA CASTELLANIa, ELENA RASCHIb, M. ORIETTA BORGHIbc, PIER LUIGI MERONIbc AND ALESSANDRO CARUSOa

a Department of Obstetrics and Gynecology, Università Cattolica del Sacro Cuore, Rome, Italy b Allergy, Clinical Immunology & Rheumatology Unit, IRCCS Istituto Auxologico Italiano, University of Milan, Milan, Italy c Department of Internal Medicine, University of Milan, Milan, Italy

Key Words: beta-2 glycoprotein I • antiphospholipid antibodies • trophoblast • fetal loss • apoptosis

Address for correspondence: Pier Luigi Meroni, M.D., Allergy, Clinical Immunology & Rheumatology Unit, IRCCS Istituto Auxologico Italiano, Via G. Spagnoletto, 3, 20149 Milan, Italy. Voice: +39-02-61911-2553; fax: +39-02-61911-2559. e-mail: pierluigi.meroni{at}unimi.it

Antiphospholipid antibodies (aPLs) reacting with beta-2 glycoprotein I (beta2GPI) have been associated with recurrent fetal loss and pregnancy complications. The aim of the study was to investigate whether aPLs with anti-beta2GPI specificity induce apoptosis of human trophoblasts in vitro. To this end, human anti-beta2GPI monoclonal IgM derived from a patient with antiphospholipid syndrome and a human irrelevant monoclonal IgM were incubated with human trophoblast cell cultures for 24, 48, and 72 h. In all the cultures we evaluated: (i) Bcl-2 and Bax mRNA and protein expression by Western blot and reverse transcription polymerase chain reaction (RT-PCR), respectively; (ii) DNA fragmentation by a commercial ELISA kit and by agarose gel electrophoresis; and (iii) the percentage of cells reactive with the monoclonal antibody (MAb) M30 by indirect immunofluorescence. The results were: Bcl-2/Bax ratio increased in untreated trophoblast cells during the time of culture, showing the highest values detectable after 72 h (2.68 and 2.28 at protein and mRNA levels, respectively). Cell incubation with anti-beta2GPI MAbs induced a significant Bcl-2/Bax ratio reduction in comparison with untreated cells (1.22 and 1.28 at protein and mRNA levels, respectively, after 72 h incubation). No significant difference was detected after cell exposure to irrelevant MAbs. However, neither DNA fragmentation nor increase in cells positive for the caspase-cleaved epitope of cytokeratin 18 cytoskeletal protein (M30) was found. In Conclusion, anti-beta2GPI antibodies react with trophoblast cells and reduce the Bcl-2/Bax ratio, but without any clear apoptotic effect.




This article has been cited by other articles:


Home page
Int ImmunolHome page
M. Blank, L. Anafi, G. Zandman-Goddard, I. Krause, S. Goldman, E. Shalev, R. Cervera, J. Font, M. Fridkin, H.-J. Thiesen, et al.
The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model
Int. Immunol., July 1, 2007; 19(7): 857 - 865.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
N. DI SIMONE, M. P. LUIGI, D. MARCO, D. N. FIORELLA, D. SILVIA, D. M. CLARA, and C. ALESSANDRO
Pregnancies Complicated with Antiphospholipid Syndrome: The Pathogenic Mechanism of Antiphospholipid Antibodies: A Review of the Literature
Ann. N.Y. Acad. Sci., June 1, 2007; 1108(1): 505 - 514.
[Abstract] [Full Text] [PDF]



footerLeft footerRight